---
schema_version: "secwatch.filing_event.v1"
accession: "0001601830-23-000061"
form_type: "8-K/A"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2023-08-11T23:59:59+00:00"
generated_at: "2026-06-11T14:32:34.155462+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Recursion adopts annual Say-on-Pay vote after shareholder majority

## Summary
- At June 16, 2023 annual meeting, majority of votes favored annual advisory Say-on-Pay votes.
- Board determined to hold annual Say-on-Pay votes until next shareholder frequency vote.
- Decision disclosed via amendment to original 8-K filed June 20, 2023.

## SEC filing metadata
- accession: 0001601830-23-000061
- form_type: 8-K/A
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2023-08-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000061/0001601830-23-000061-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000061/rxrx-20230616.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001601830-23-000061
- JSON: https://secwatch.observer/filing/0001601830-23-000061.json
- Plain text: https://secwatch.observer/filing/0001601830-23-000061.txt

## Key facts
- Shareholder Votes
  RECURSION PHARMACEUTICALS, INC. shareholders approved Advisory vote on frequency of future shareholder advisory votes regarding named executive officer compensation at the 2023-06-16 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-06-16
  source text: Consistent with the recommendation of the Company’s Board of Directors (the “Board”), a majority of the votes at the Annual Meeting were cast in favor of conducting advisory Say-on-Pay votes on an annual basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1601830/000160183023000061/0001601830-23-000061-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.